Celera Shifts Focus To Clinical Diagnostics, Deserting Drug Development
This article was originally published in The Pink Sheet Daily
Executive Summary
In revamping its business strategy away from drug development, the biotech firm assumes sole ownership of Celera Diagnostics from sister company Applied Biosystems.
You may also be interested in...
J&J Sues Boston Scientific, Abbott For $5.5 Bil For Breach Of Contract
After losing bidding war for Guidant, J&J charges winning firms with using leaked information.
State Drug Advertising Laws Foreshadow Future Device Regulation
Some state lawmakers contend that industry's voluntary code of ethics is insufficient, according to Kyphon's chief compliance officer.
FDA Official Distinguishes Scientific Exchange From Off-Label Promotion
Agency compliance head Tim Ulatowski says he's not concerned about the scientific exchange of information on products.